T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy ; volume:8 ; number:1 ; day:8 ; month:8 ; year:2023 ; pages:1-10 ; date:12.2023
npj Genomic Medicine ; 8, Heft 1 (8.8.2023), 1-10, 12.2023
- Creator
-
Miyashita, Hirotaka
Kurzrock, Razelle
Bevins, Nicholas J.
Thangathurai, Kartheeswaran
Lee, Suzanna
Pabla, Sarabjot
Nesline, Mary
Glenn, Sean T.
Conroy, Jeffrey M.
DePietro, Paul
Rubin, Eitan
Sicklick, Jason K.
Kato, Shumei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41525-023-00359-8
- URN
-
urn:nbn:de:101:1-2024020515064377177025
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Miyashita, Hirotaka
- Kurzrock, Razelle
- Bevins, Nicholas J.
- Thangathurai, Kartheeswaran
- Lee, Suzanna
- Pabla, Sarabjot
- Nesline, Mary
- Glenn, Sean T.
- Conroy, Jeffrey M.
- DePietro, Paul
- Rubin, Eitan
- Sicklick, Jason K.
- Kato, Shumei
- SpringerLink (Online service)
Other Objects (12)
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Next-generation immunotherapy to counteract T-cell exhaustion
The role of T-cell exhaustion for cancer immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Transcriptomic characterization and improvement of immunotherapy in Merkel cell carcinoma
AIT (allergen immunotherapy): a model for the “precision medicine”
Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy
Cardiomyocytes display low mitochondrial priming and are highly resistant toward cytotoxic T‐cell killing
DNGR‐1 is dispensable for CD8 + T‐cell priming during respiratory syncytial virus infection
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Next-generation immunotherapy to counteract T-cell exhaustion
The role of T-cell exhaustion for cancer immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Transcriptomic characterization and improvement of immunotherapy in Merkel cell carcinoma
AIT (allergen immunotherapy): a model for the “precision medicine”
Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy
Cardiomyocytes display low mitochondrial priming and are highly resistant toward cytotoxic T‐cell killing
DNGR‐1 is dispensable for CD8 + T‐cell priming during respiratory syncytial virus infection
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Next-generation immunotherapy to counteract T-cell exhaustion
The role of T-cell exhaustion for cancer immunotherapy
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Transcriptomic characterization and improvement of immunotherapy in Merkel cell carcinoma
AIT (allergen immunotherapy): a model for the “precision medicine”
Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy
Cardiomyocytes display low mitochondrial priming and are highly resistant toward cytotoxic T‐cell killing